Pay in 4 interest-free payments of $5.49 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Krop J, ZwanVan Der Zwan A, Ijsselsteijn ME, et al
Tirzepatide dose ranges (2.5-15 mg) are significantly higher than semaglutide dose ranges (0.25-2.4 mg), which means syringe capacity becomes a limiting factor much earlier with tirzepatide
Dual Incretin Signaling# GLP-1R activation : Enhances glucose-dependent insulin secretion, suppresses glucagon, slows gastric emptying, reduces appetite via hypothalamic signaling GIPR activation : Potentiates insulin secretion, may improve lipid metabolism and fat distribution, enhances central appetite regulation Synergistic effects : The combination produces greater glycemic and weight effects than either pathway alone Pharmacokinetics# The C20 fatty diacid modification enables albumin binding, yielding a half-life of approximately 5 days and supporting once-weekly administration
If you are using a syringe, use only the amount your provider showed you how to measure
Marc Jean-Gilles, DO, FACOG , offers personalized advice, ensuring each patient receives the most appropriate treatment tailored to their needs
US$ 26.65
US$ 26.45
US$ 25.70
